ATLANTA, Dec. 2, 2015 (GLOBE NEWSWIRE) -- The Genetics Policy Institute (GPI) and Regenerative Medicine Foundation (RMF) announced that the second annual RegMed Capital Conference (RMCC) will be hosted as a co-located meeting at the 11th annual World Stem Cell Summit, December 10-12 at the Hyatt Regency Atlanta.
"The RegMed Capital Conference is designed to attract new money to our field and provides actionable intelligence supporting both industry and the investment communities. Company presentations will showcase new developments and clinical trial results to the investor community. RMCC introduces executives to a qualified audience of investment bankers, venture capitalists and angel capital investors," said Bernard Siegel, Founder of the World Stem Cell Summit & RegMed Capital Conference and Executive Director of GPI.
The RegMed Capital Conference is fully integrated into the World Stem Cell Summit platform, providing attendees a complete 360-degree view of the Regenerative Medicine industry, stem cell science, clinical trials and regulation along with investment opportunities for companies targeting cures. Designed to build relationships and collaboration, the conference includes a sophisticated on-site partnering forum powered by JuJama. This custom mobile app allows attendees to identify people they want to meet, ask for a meeting and have it automatically fit into their schedules at the conference.
"The past World Stem Cell Summit & RegMed Capital Conference was a bonanza for StemBioSys," said Bob Hutchens, President and CEO of StemBioSys. "As a growing company in the stem cell space, preparing to launch our first product in 2015, the connections and ongoing collaborations that we made at these meetings has already exhibited a multifold return on investment in spreading the word about SBS and uncovering several new opportunities for business and product development."
The RegMed Capital Conference will provide some of the most innovative companies in the world the opportunity to make executive presentations to the investment community. A partial list of presenting companies include:
• ArunA Biomedical
• Bell Biosystems
• BioLeonhardt MyoStim
• Cellular BioMedicine
• Fujifilm Corporation
• Harvard Apparatus Regenerative Technology
• Neural Stem Cell Institute
• RegenMed Systems
• Rooster Bio
• Shenzhen Cell Technology Co., Ltd.
A sample of noted investment banks, asset management firms, venture firms and angel-networks that are committed to the RMCC program includes:
• Excel Venture Management, LLC
• Keiretsu Forum (largest angle network of accredited investors)
• Livingston Securities LLC
• Medtown Ventures
• The Merchants Financial Group, Ltd.
• Piper Jaffray
• Proteus Venture Partners
• Raymond James & Associates
• WBB Securities
"The RegMed conference and the WSCS are really the best conferences I've ever attended," said Jane Andrews, Ph.D. of Frost & Sullivan. "I think the main reason for this is because the Summit hosts convey a sense of congeniality, compassion and have a firm belief in Regenerative Medicine as a game changer for modern medicine. As a result, there's a sense of commitment, excitement and sharing that runs through the conference, making it an open forum for learning and connecting."
The recently merged, Genetics Policy Institute/Regenerative Medicine Foundation, is a 501c3 nonprofit public interest organization, with the mission to promote public awareness, societal support and public policy initiatives for the fields of regenerative medicine, stem cell research and other advanced therapies, thereby accelerating their application in medicine for the purpose of delivering cures. We pursue this mission through production of our flagship annual World Stem Cell Summit & RegMed Capital Conference, publication of the annual World Stem Cell Report and newsletters, Stem Cell Action Awards, the Stem Cell Action Coalition, social media campaigns, special projects, speaking engagements, teaching initiatives and strategic collaborations. Learn more at www.genpol.org.
The 11th Annual World Stem Cell Summit & RegMed Capital Conference, the flagship meeting of the international stem cell community, is organized by the Genetics Policy Institute. The Summit (WSCS15) is organized by Genetics Policy Institute/Regenerative Medicine Foundation, The Georgia Center for Regenerative Engineering & Medicine (Emory University, Georgia Tech, University of Georgia), Mayo Clinic, Kyoto University Institute for Cell-Material Sciences (iCeMS), BioBridge Global, Wake Forest Institute for Regenerative Medicine and The New York Stem Cell Foundation. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. The Summit forges collaborations to advance cell therapies, while creating a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy.
Register at www.WorldStemCellSummit.com.
Follow @WSCSummit on Twitter.
Judith Selzer 561.909.8415